Ultrasound Study of Entheses and Small Joints of Hands and Feet in Patients With Atypical Form of Psoriasis

Sonographic Analysis of Nails in Psoriatic Arthritis and Healthy Controls

NCT04718428 ·Status: COMPLETED

Study of Psoriatic Arthritis

NCT00001420 ·Status: COMPLETED

Premature Coronary Artery Disease (CAD) in Severe Psoriasis

NCT00893126 ·Status: COMPLETED

Safety and Efficacy of Etanercept in Patients With Psoriasis

NCT02258282 ·Status: UNKNOWN ·Phase: NA

Psoriasis Longitudinal Assessment and Registry

NCT00508547 ·Status: ACTIVE_NOT_RECRUITING

Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis

NCT02829424 ·Status: TERMINATED ·Phase: PHASE4

Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet

NCT00585650 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

An Efficacy and Safety Study of Ustekinumab (CNTO 1275) in Participants With Plaque Psoriasis

NCT00723528 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

NCT01172938 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Efficacy and Safety of XP23829 in Subjects With Moderate-to-Severe Chronic Plaque-Type Psoriasis

NCT02173301 ·Status: COMPLETED ·Phase: PHASE2

A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting

NCT07220824 ·Status: RECRUITING

A Study to Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting Ustekinumab

NCT03336281 ·Status: COMPLETED

A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents

NCT01077362 ·Status: COMPLETED ·Phase: PHASE3

Association Between the Occurrence of a Clinical RElapse and Gut MIcrobiota Modifications: a Cohort Study of Patients With pSOriasis

NCT06055699 ·Status: NOT_YET_RECRUITING

Exploration of the Cellular and Molecular Mechanisms in Patients Receiving Biotherapies Targeting the IL-23/IL-17 Axis in Cutaneous Psoriasis

NCT05111210 ·Status: RECRUITING

Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

NCT00227240 ·Status: COMPLETED

Observational Safety Study of Etanercept (Enbrel) for Treatment of Psoriasis

NCT00322439 ·Status: COMPLETED

Study Evaluating The Prevalence Of Undiagnosed Psoriatic Arthritis In Patients With Plaque Psoriasis

NCT00998829 ·Status: COMPLETED

A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate

NCT01059773 ·Status: COMPLETED ·Phase: PHASE4

A Study to Determine the Efficacy and Safety of 122-0551 in Subjects With Plaque Psoriasis

NCT01700985 ·Status: COMPLETED ·Phase: PHASE2

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs

NCT04908202 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis

NCT00534313 ·Status: TERMINATED ·Phase: PHASE2

Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study

NCT01522742 ·Status: TERMINATED

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor Treatment

NCT04908189 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT02223039 ·Status: COMPLETED ·Phase: PHASE2